Skip to content
10-Q

Quarterly Report

Eucrates Biomedical Acquisition Corp.

0001410578-21-000388

← back to feed
Filed
Nov 22, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 22, 2021 13.46M sh
Total Liabilities Q3 2021 · Sep 30, 2021 $6.27M
Total Liabilities Q3 2021 · Dec 31, 2020 $10.34M
Current Assets Q3 2021 · Sep 30, 2021 $490.22K
Current Assets Q3 2021 · Dec 31, 2020 $1.02M
Total Assets Q3 2021 · Sep 30, 2021 $105.32M
Total Assets Q3 2021 · Dec 31, 2020 $105.83M
Cash And Equivalents restated Q3 2021 · Sep 30, 2020 $85.23K
Cash And Equivalents Q3 2021 · Aug 20, 2020 $0
Stockholders Equity restated Q3 2021 · Sep 30, 2020 −$21.92K
Stockholders Equity Q3 2021 · Aug 20, 2020 $0
Net Income Q3 2021 · Sep 30, 2020 −$3.08K
Operating Income Q3 2021 · Sep 30, 2020 −$3.08K